Young lung cancer patients undergoing surgery: Comparison of clinicopathological characteristics and outcomes in patients aged ≤50 years versus >50 years
Recognizing lung cancer as a differential diagnosis for patients aged 50 years or younger is crucial because this group shows superior outcomes for stage I disease. Lymphovascular invasion is an independent prognostic risk factor across age groups.
Authors
- Steven Swanson (ORCID: https://orcid.org/0000-0002-5896-1037)
- Paula A. Ugalde (ORCID: https://orcid.org/0000-0003-4284-444X)
- Evert A Sugarbaker (ORCID: https://orcid.org/0009-0006-0662-5847)
- Ali Basil Ali (ORCID: https://orcid.org/0000-0003-4592-359X)
- Michael T. Jaklitsch (ORCID: https://orcid.org/0000-0003-4018-9955)
- Rafael Ribeiro Barcelos
- Miles McAllister (ORCID: https://orcid.org/0009-0004-8191-3553)
- Anupama Singh (ORCID: https://orcid.org/0000-0001-7776-4584)
- Roberto Leo
- Raphael Bueno
Institutions
- Brigham and Women's Hospital (US)
Publication Details
- Journal
- JTCVS Open
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1016/j.xjon.2024.12.008
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42